Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Correction notification: Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 07.08.2019 / 11:51 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. - Share buy-back - 7th Interim Report (correction notification) In the period from July 29, 2019 until and including August 2, 2019, a total of 63,746 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 29/07/2019 26,119 67.6737 30/07/2019 34,871 64.3697 31/07/2019 - - 01/08/2019 - - 02/08/2019 - -   Chi-X Europe Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 29/07/2019 - - 30/07/2019 2,756 63.0920 31/07/2019 - - 01/08/2019 - - 02/08/2019 - -   The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including August 2, 2019 therefore amounts to 1,534,327 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., August 5, 2019 07.08.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

853291  07.08.2019